C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output.
Adipose tissue-derived adipokines play important roles in controlling systemic insulin sensitivity and energy balance. Our recent efforts to identify novel metabolic mediators produced by adipose tissue have led to the discovery of a highly conserved family of secreted proteins, designated as C1q/TNF-related proteins 1-10 (CTRP1 to -10). However, physiological functions regulated by CTRPs are largely unknown. Here we provide the first in vivo functional characterization of CTRP3. We show that circulating levels of CTRP3 are inversely correlated with leptin levels; CTRP3 increases with fasting, decreases in diet-induced obese mice with high leptin levels, and increases in leptin-deficient ob/ob mice. A modest 3-fold elevation of plasma CTRP3 levels by recombinant protein administration is sufficient to lower glucose levels in normal and insulin-resistant ob/ob mice, without altering insulin or adiponectin levels. The glucose-lowering effect in mice is linked to activation of the Akt signaling pathway in liver and a marked suppression of hepatic gluconeogenic gene expression. Consistent with its effects in mice, CTRP3 acts directly and independently of insulin to regulate gluconeogenesis in cultured hepatocytes. In humans, alternative splicing generates two circulating CTRP3 isoforms differing in size and glycosylation pattern. The two human proteins form hetero-oligomers, an association that does not require interdisulfide bond formation and appears to protect the longer isoform from proteolytic cleavage. Recombinant human CTRP3 also reduces glucose output in hepatocytes by suppressing gluconeogenic enzyme expression. This study provides the first functional evidence linking CTRP3 to hepatic glucose metabolism and establishes CTRP3 as a novel adipokine.
Department of Physiology and Center for Metabolism and Obesity Research, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Jonathan M
JM
Peterson
Zhikui
Z
Wei
G William
GW
Wong
D054392:Adipokines / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D052242:Adiponectin / Q000097:blood / Q000235:genetics; D017398:Alternative Splicing / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001483:Base Sequence; D001786:Blood Glucose / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D005215:Fasting / Q000097:blood; D005943:Gluconeogenesis / Q000187:drug effects / Q000502:physiology*; D057809:HEK293 Cells; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood; D008099:Liver / Q000378:metabolism*; D051379:Mice; D008820:Mice, Obese; D008969:Molecular Sequence Data; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D048069:Tumor Necrosis Factors / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology
C499918:ADIPOQ protein, human; D054392:Adipokines; D052242:Adiponectin; C499919:Adipoq protein, mouse; D001786:Blood Glucose; C506069:C1QTNF3 protein, human; C000590534:C1q tumor necrosis factor-related protein 3, rat; D007328:Insulin; D020738:Leptin; D020033:Protein Isoforms; D048069:Tumor Necrosis Factors